Chicago Capital LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Chicago Capital LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,575 shares of the medical equipment provider’s stock after acquiring an additional 2,331 shares during the quarter. Chicago Capital LLC’s holdings in Intuitive Surgical were worth $15,512,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Creekmur Asset Management LLC raised its position in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC purchased a new position in shares of Intuitive Surgical in the second quarter worth about $26,000. Delos Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 57 shares during the period. LRI Investments LLC bought a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. Finally, LGT Financial Advisors LLC increased its stake in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of analyst reports. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a research report on Friday. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Raymond James boosted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $521.15 on Friday. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $523.34. The firm has a 50-day moving average of $483.85 and a 200 day moving average of $438.17. The stock has a market cap of $184.85 billion, a P/E ratio of 94.07, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business’s revenue was up 14.5% on a year-over-year basis. During the same period last year, the business earned $1.18 earnings per share. Research analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mark Brosius sold 2,115 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the sale, the insider now owns 295 shares in the company, valued at approximately $145,113.45. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 53,120 shares of company stock valued at $25,528,753 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.